
|Videos|April 7, 2021
Opioid-free ureteroscopy initiatives appear to be reducing new-persistent opioid use
Author(s)Urology Times staff
“This paper shows that our efforts to reduce… opioid exposure in the postoperative setting is reducing new persistent opioid use,” says Matthew S. Lee, MD.
Advertisement
In this video, Matthew S. Lee, MD, discusses the recent Urology paper, “Opioid Free Ureteroscopy: what is the true failure rate?” for which he served as a study author. Lee was an endourology fellow at Indiana University at the time of the study and is currently a clinical instructor at Northwestern University Feinberg School of Medicine.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA provides guidance on development pathway for testosterone therapy for women
2
Pearls & Perspectives: Leadership and Prostate Cancer, with Mark L. Gonzalgo, MD, PhD, MBA
3
Pedro Freitas, MD, on consolidative surgery vs prolonged systemic therapy in MIBC
4
Treatment Selection in Advanced Prostate Cancer
5






